Showing results (81-90 of 92) with videos related to

Sort By:
Pageof 10
Journal of Medicinal Chemistry|May 8, 2009
Discovery of 4-(5-(4-chlorophenyl)-2-methyl-3-propionyl-1H-pyrrol-1-yl)benzenesulfonamide (A-867744) as a novel positive allosteric modulator of the alpha7 nicotinic acetylcholine receptorRamin Faghih, Sujatha M Gopalakrishnan, Jens Halvard Gronlien, et al.
Journal of the American Society of Nephrology : JASN|August 23, 2017
Targeting Anti-TGF-β Therapy to Fibrotic Kidneys with a Dual Specificity Antibody ApproachSteve McGaraughty, Rachel A Davis-Taber, Chang Z Zhu, et al.
British Journal of Pharmacology|August 11, 2004
In vitro and in vivo characterization of a novel naphthylamide ATP-sensitive K+ channel opener, A-151892Murali Gopalakrishnan, Steven A Buckner, Char-Chang Shieh, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 18, 2002
(-)-(9S)-9-(3-Bromo-4-fluorophenyl)-2,3,5,6,7,9-hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide (A-278637): a novel ATP-sensitive potassium channel opener efficacious in suppressing urinary bladder contractions. I. In vitro characterizationMurali Gopalakrishnan, Steven A Buckner, Kristi L Whiteaker, et al.
Journal of Medicinal Chemistry|May 28, 2004
Synthesis and structure-activity relationships of a novel series of tricyclic dihydropyridine-based KATP openers that potently inhibit bladder contractions in vitroWilliam A Carroll, Konstantinos A Agrios, Robert J Altenbach, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 21, 2012
Pharmacological properties and procognitive effects of ABT-288, a potent and selective histamine H3 receptor antagonistTimothy A Esbenshade, Kaitlin E Browman, Thomas R Miller, et al.
CNS Drug Reviews|June 5, 2004
ABT-089: pharmacological properties of a neuronal nicotinic acetylcholine receptor agonist for the potential treatment of cognitive disordersLynne E Rueter, David J Anderson, Clark A Briggs, et al.
Biochemical Pharmacology|May 31, 2011
Potentiation of analgesic efficacy but not side effects: co-administration of an α4β2 neuronal nicotinic acetylcholine receptor agonist and its positive allosteric modulator in experimental models of pain in ratsChang Z Zhu, Chih-Liang Chin, Nathan R Rustay, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 28, 2007
Broad-spectrum efficacy across cognitive domains by alpha7 nicotinic acetylcholine receptor agonism correlates with activation of ERK1/2 and CREB phosphorylation pathwaysRobert S Bitner, William H Bunnelle, David J Anderson, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 28, 2010
In vitro pharmacological characterization of a novel selective alpha7 neuronal nicotinic acetylcholine receptor agonist ABT-107John Malysz, David J Anderson, Jens H Grønlien, et al.
Pageof 10